Navigation Links
Using the Internet to Promote Exercise
Date:9/12/2007

TAMPA, Fla., Sept. 12 /PRNewswire/ -- Using the Internet to promote exercise seems like an oxymoron. "Certainly, sitting in front of a computer all day is not what we want people to be doing," says Stan Reents, PharmD, a certified personal trainer, fitness counselor, and tennis coach.

Nevertheless, the Internet is a highly effective way to deliver information right to the person who needs it. "The Internet is as much a part of American society as the automobile and the television, so we should take advantage of that when trying to reach people on an individual basis," says Reents.

Surveys by the Pew Internet & American Life Project (http://www.PewInternet.org) routinely show more and more US households with Internet access. The most recent survey from earlier this year revealed that 71% of adults have access to the Internet. This trend is expected to continue.

"I use the Internet to search for information every single day," says Reents, author of the text "Sport and Exercise Pharmacology" and creator of http://www.AthleteInMe.com.

While the Internet allows consumers to be in control of the information they receive, it also has created a situation where questionable information is freely dispensed. "It's a quality vs. quantity thing. Consumers need to be able to identify reputable sources. This is especially important when it comes to health and fitness information," says Reents, who is a former health care professional.

Some things to look for when evaluating health and fitness web sites are: What is the author's background and qualifications? Is there an editorial review process? Are facts and controversial statements substantiated? What is the source of funding? (ie., is there any conflict-of-interest?).

"All of the content on AthleteInMe.com is thoroughly researched before being posted," says Reents. "I'm compuls
'/>"/>

SOURCE AthleteInMe, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
3. Researchers urge caution in using ear tube surgery
4. Surgery using gene therapy for Alzheimer’s patient
5. Protein causing spread of colon cancer identified
6. Relief to pregnant women using fertility drugs
7. The hazards of using disinfectant hand gel
8. Ulcer causing bug found in stored food
9. Colon cancer risk linked to genes causing Hemochromatosis
10. Teens Misusing Nicotine-Replacement Products
11. Head injury X-rays may actually be causing harm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ug. 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (N...ors declared a regular,quarterly cash dividend of ...008. The dividend will be paid on October 3, 2008,... About Landauer, Landauer is the leading provide... and environmental radiation exposure. For more th...
(Date:8/29/2008)...fic obligation reduced from $250 to $19 million, ...oston Scientific,Corporation (NYSE: BSX ) today a... Texas found two patents of Medtronic, Inc. (NYSE:...ng the prosecution of the patents,before the Unite... previously found that certain Boston Scientific b...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for O...ia to provide protection for cash paying patients ...ic community is benefiting. , .... Milton Owens and the Coastal Center for Obesity ...rovide protection for cash paying patients in the ...
(Date:8/29/2008)... Trusted life science software provider allows...ngage via GSA. , Reston, ...erging software engineering firm dedicated to the...ral Services Administration (GSA) Contract. The GS...h the ability to conveniently engage 5AM Solutions...
Breaking Medicine News(10 mins):Health News:Court Rejects Two Medtronic Patents 2Health News:Court Rejects Two Medtronic Patents 3Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2
...ccording to a recent study, are increasingly turni...ease. In this context physicians need to be aware...de the patients to the most reliable, accurate and...niversity of Pennsylvania Cancer Center in Philade...
...ems to be the latest mantra of Pfizer. The pharma...ree antifungal drug to 50 countries hardest hit by...close on the heels of the South African Government...ompanies. In an announcement on Wednesday Pfizer ...
...ich are protective substances, produced by the bod...em kill the TB bacteria, researchers in the UK rep...he journal Nature Medicine, these heat-shock prote...ody help cells survive stressful times and bolster...
...rket in India is expected to grow into a three bil...ndia finance report. The big leap is expected to ...one billion dollars. Biogenerics, biopharmaceutic...tors are all poised for the big leap, both nationa...
Other Medicine News:
(Date:8/26/2008)...stCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today anno...om the CUSTOM II trial was published in the most r...rvention. The lead author of the article was,Dr. P...r Utrecht, Utrecht,The Netherlands on behalf of t...across Europe., The one-year CUSTOM II trial, a s...
(Date:8/25/2008).../ -- Joseph F. Finn, Jr.,C.P.A. ("Finn"), Assigne...,the benefit of creditors, announced today that al...d at a sealed bid auction on October 10,2008., S...opa-Carbidopa that,is the current gold standard tr... estimated at approximately $250 million. Signific...
(Date:8/22/2008)..., - Dangerous Bacteria Infect Three Million Peopl...tried can also be innovative: already in,Ancient G...ial. This,ability is now playing an important role... In a worldwide noted field test, a whole hospital...rg, Germany, was equipped with,door handles, door ...
(Date:8/21/2008)...tial in independent study of ad...g. 21 /- A recently published article...ation has expanded our,understanding of the clinic...in adult patients at risk for organ rejection or i...ablo Sanchez-Velasco and his colleagues in the Can...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 2New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 3Commonwealth Fund Commission issues reform recommendations for next president 6383 1Commonwealth Fund Commission issues reform recommendations for next president 6383 2Commonwealth Fund Commission issues reform recommendations for next president 6383 3FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 1FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 2FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 3FDA Hears Pros Cons of Pharmacist to Patient Drug Sales 6381 4BIO key Reports Third Quarter 2007 Results 1228 1BIO key Reports Third Quarter 2007 Results 1228 2BIO key Reports Third Quarter 2007 Results 1228 3BIO key Reports Third Quarter 2007 Results 1228 4BIO key Reports Third Quarter 2007 Results 1228 5Predicting the future in ovarian cancer 6379 1Predicting the future in ovarian cancer 6379 2
...USINESS WIRE)--Jun 7, 2007 - Clinical results from...the American,Headache Society (AHS) annual meeting...itonin gene-related peptide (CGRP),receptor antago...two hours after dosing compared to placebo, and th...as generally well tolerated in,the study. Response...
... 900-mcg dosed every two weeks achieved an SVR rat...(ITT analysis), with,more favorable quality-of-lif...ire-FirstCall/ -- Human,Genome Sciences, Inc. toda...2b clinical trial of Albuferon(R) (albinterferon a...-naive patients with,genotype 1 chronic hepatitis ...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
...nterior Spinal Implant system. Material that has a...cal bone. The result is an implant that meets the ..., while optimizing the fusion environment through ...omic design with 5 and 10 degrees of lordosis. Min...
...Cage System provides anterior column support for s...ctomies from T1 to L5. The system consists of one ...tacked to a desired height, accommodating various ...lymer material emulates the biomechanical properti...
The primary goals in interbody fusion are to immobilize the affected vertebrae, to restore disc space height and sagittal alignment, and to provide an enviroment for bone fusion between vertebral bod
Flexoscope images are transmitted through sorted fiberglass bundles that record the picture and transmit it to a user's eye. Karl Storz flexoscopes are designed for rough, industrial handling and can
Medicine Products: